Effectiveness of sitagliptin in Cystic Fibrosis with impaired glucose tolerance

Brief Description Of Study

This study will evaluate how effective sitagliptin, a DPP-IV inhibitor, is at improving glycemic control in the Cystic Fibrosis population.

Clinical Study Identifier: 818014

Detailed Study Description

This trial will evaluate the participant's metabolic response pre- and post-treatment using a Mixed Meal Tolerance Test and a Glucose Potentiated Arginine Test.

Additional Information About The Study

The above is a very brief overview. ' Please contact the Research Coordinator for further questions at jack.eiel@uphs.upenn.edu or call 215-746-2081



Contact research investigator to learn more about this study by filling out the form below.


To: Research Study Investigator
Subject: I am interested in participating in your Research Study
Dear Investigator,
I'm interested in learning more about and participating in your research study named: Effectiveness of sitagliptin in Cystic Fibrosis with impaired glucose tolerance
Included below is some of my health information:
  1. Condition = Cystic fibrosis
I am hoping to hear back from you and discuss details of the study

By clicking "Contact Research Team", your contact information will be sent directly to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.